Free Trial

Trellus Health (TRLS) Competitors

GBX 2.38 -0.22 (-8.46%)
As of 03:33 AM Eastern

TRLS vs. INHC, IQAI, FDBK, DVRG, SENS, EMIS, CRW, INS, KOO, and RENX

Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include Induction Healthcare Group (INHC), IQ-AI (IQAI), Feedback (FDBK), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), and Renalytix (RENX). These companies are all part of the "health information services" industry.

Trellus Health vs.

Trellus Health (LON:TRLS) and Induction Healthcare Group (LON:INHC) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, community ranking, media sentiment and valuation.

Induction Healthcare Group received 14 more outperform votes than Trellus Health when rated by MarketBeat users.

CompanyUnderperformOutperform
Trellus HealthN/AN/A
Induction Healthcare GroupOutperform Votes
14
93.33%
Underperform Votes
1
6.67%

Trellus Health has a net margin of 0.00% compared to Induction Healthcare Group's net margin of -23.86%. Induction Healthcare Group's return on equity of -14.53% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus HealthN/A -35.08% -22.76%
Induction Healthcare Group -23.86%-14.53%-7.32%

Induction Healthcare Group has higher revenue and earnings than Trellus Health. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£35K115.36-£6.66M-£0.03-83.33
Induction Healthcare Group£13.65M0.56-£3.25M-£0.03-270.37

Trellus Health has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500. Comparatively, Induction Healthcare Group has a beta of -0.41, indicating that its stock price is 141% less volatile than the S&P 500.

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled Induction Healthcare Group'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
Induction Healthcare Group Neutral

19.3% of Trellus Health shares are owned by institutional investors. Comparatively, 46.3% of Induction Healthcare Group shares are owned by institutional investors. 49.7% of Trellus Health shares are owned by company insiders. Comparatively, 54.6% of Induction Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Induction Healthcare Group beats Trellus Health on 7 of the 11 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRLS vs. The Competition

MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£4.04M£200.65M£5.39B£2.04B
Dividend YieldN/A6.94%5.37%5.16%
P/E Ratio-83.33537.3688.911,926.65
Price / Sales115.36828.491,280.48384,006.48
Price / Cash0.7647.1436.6029.21
Price / Book0.255.404.963.08
Net Income-£6.66M-£8.11M£117.89M£183.60M
7 Day Performance-21.88%1.08%1.68%1.24%
1 Month Performance350.45%14.22%3.63%3.43%
1 Year Performance-44.57%13.13%26.16%43.35%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 2.38
-8.5%
N/A-50.0%£3.84M£35,000.00-79.3331Gap Up
INHC
Induction Healthcare Group
N/AGBX 8.11
-4.6%
N/A-56.2%£7.61M£13.65M-270.3774
IQAI
IQ-AI
N/AGBX 1.75
-6.3%
N/A-46.9%£3.88M£538,190.00-13.676
FDBK
Feedback
N/AGBX 19.78
-0.1%
N/A-71.3%£2.64M£1.18M-79.1224
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
1.9189 of 5 stars
GBX 2,040
-0.5%
GBX 2,700
+32.4%
+3.6%£720.94M£189.27M7,846.15734
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
3.0371 of 5 stars
GBX 178
+0.3%
GBX 585
+228.7%
-39.0%£64.93M£54.17M1,483.33478Positive News
RENX
Renalytix
N/AGBX 11.40
-3.0%
N/A+1.3%£18.92M£2.29M-47.50102Gap Down

Related Companies and Tools


This page (LON:TRLS) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners